Trial intelligence / Profile preview

CHEST trial of hydroxyethyl starch versus saline for ICU fluid resuscitation

ACTRN12609000245291Phase 4Completed

Sponsor
The George Institute for Global Health
Start
Dec 2009
Modality
Small Molecules
Countries
2
01

Overview

Phase 4, randomised trial of hetastarch and sodium chloride in critical illness and hypovolemia (2 arms), sponsored by The George Institute for Global Health. Primary endpoint: All-cause mortality. Started Dec 2009; status: completed.

02

Drugs

hetastarchsodium chloride
03

Conditions

critical illnesshypovolemia

Beyond the preview

Go deeper on ACTRN12609000245291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12609000245291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call